Chemomab Therapeutics (CMMB) Assets (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.68% |
| Sep 30, 2025 | 11.13% |
| Jun 30, 2025 | -13.18% |
| Mar 31, 2025 | -24.43% |
| Dec 31, 2024 | -18.82% |
| Sep 30, 2024 | 43.68% |
| Jun 30, 2024 | -19.24% |
| Mar 31, 2024 | -18.70% |
| Dec 31, 2023 | -5.41% |
| Sep 30, 2023 | -18.83% |
| Jun 30, 2023 | -17.60% |
| Mar 31, 2023 | -18.69% |
| Dec 31, 2022 | -14.25% |
| Sep 30, 2022 | -10.92% |
| Jun 30, 2022 | -7.51% |
| Mar 31, 2022 | -5.28% |
| Dec 31, 2021 | -4.58% |
| Sep 30, 2021 | -4.36% |
| Jun 30, 2021 | 17.29% |
| Mar 31, 2021 | 381.91% |
| Dec 31, 2020 | 62.26% |
| Sep 30, 2020 | -23.23% |
| Jun 30, 2020 | -34.03% |
| Mar 31, 2020 | -23.14% |
| Dec 31, 2019 | -35.98% |
| Sep 30, 2019 | -0.64% |
| Jun 30, 2019 | -15.56% |
| Mar 31, 2019 | 188.22% |